Related Experiment Video
Updated: Jun 21, 2026

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
Published on: November 4, 2021
Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological
Joost De Haeck1, Niels J W Verouden, José P S Henriques
1Department of Cardiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. j.d.haeck@amc.uva.nl
Insights
Distal embolization during percutaneous coronary intervention can cause microvascular obstruction, known as the no-reflow phenomenon. This review discusses strategies to prevent and treat this complication, improving patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Distal embolization is a complication of percutaneous coronary intervention (PCI).
- It can lead to microvascular obstruction and the 'no-reflow' phenomenon, impairing myocardial perfusion.
- This phenomenon is associated with poor patient outcomes, particularly in saphenous vein graft interventions and primary PCI.
Purpose of the Study:
- To review the incidence and impact of distal embolization during PCI.
- To discuss current and emerging strategies for preventing and treating distal embolization.
- To explore future directions in managing microvascular obstruction post-PCI.
Main Methods:
- Literature review of clinical trials and studies on distal embolization during PCI.
- Analysis of the pathophysiology of microvascular obstruction and the no-reflow phenomenon.
- Discussion of mechanical and pharmacological interventions.
Main Results:
- Distal embolization occurs in 2-42% of saphenous vein graft interventions and 6-15% of primary PCI.
- The 'no-reflow' phenomenon is a significant consequence, linked to impaired outcomes.
- Various preventive and therapeutic strategies have been investigated.
Conclusions:
- Distal embolization is a critical factor in PCI-related microvascular obstruction.
- Further development of preventive and therapeutic strategies is warranted.
- Effective management of distal embolization is crucial for improving PCI success rates and patient prognosis.
Abstract:
Distal embolization during percutaneous coronary intervention for acute myocardial infarction or saphenous vein graft disease may result in microvascular obstruction and the 'no-reflow' phenomenon. The incidence of distal embolization ranges from 2 to 42% in saphenous vein graft intervention and from 6 to 15% in primary percutaneous coronary intervention and is associated with impaired myocardial perfusion and poor outcome. Several mechanical and pharmacological strategies have been proposed to prevent or to treat embolization in percutaneous coronary intervention and have been tested in clinical trials. The pivotal role of distal embolization in the pathophysiology of microvascular obstruction will lead to the further development of preventive and therapeutic strategies. Strategies to counteract distal embolization and future directions are discussed in this review.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Pulmonary Embolism III: Nursing Management